There were 1,684 press releases posted in the last 24 hours and 400,964 in the last 365 days.

Hemorrhoids Market and Epidemiology Forecast 2032: Population Data, Drugs, Companies by DelveInsight

Hemorrhoids Market

Hemorrhoids Market

DelveInsight’s Hemorrhoids Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM.

LAS VEGAS, NEVADA, UNITED STATES, April 2, 2024 /EINPresswire.com/ -- The Hemorrhoids market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hemorrhoids pipeline products will significantly revolutionize the Hemorrhoids market dynamics.

DelveInsight’s “Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Hemorrhoids market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hemorrhoids Market Forecast

Some of the key facts of the Hemorrhoids Market Report:
The Hemorrhoids market size was valued approximately USD 1,112 million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
In February 2022, Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products, and stem cell therapies announced that the U.S. Food and Drug Administration (FDA) has issued a Study May Proceed letter for Halo-Lido for the treatment of hemorrhoids
In 2021, the collective number of existing cases of hemorrhoids in the 7MM was recorded at 32,990,683 cases. It is anticipated that this figure will rise by the year 2032.
In the EU4 nations and the UK, Germany recorded the highest count of diagnosed prevalent cases of hemorrhoids, totaling 3,419,219 cases in 2021.
Key Hemorrhoids Companies: Xian-Janssen Pharmaceutical Ltd., Citius Pharmaceuticals, Inc., Church & Dwight Company, Inc., Ventrus Biosciences, Inc, Citius Pharmaceuticals, Inc, Pacira Pharmaceuticals, Inc, Peritech Pharma Ltd., and others
Key Hemorrhoids Therapies: Carraghenates Cream, Monad, Anusol, Iferanserin, Hydrocortisone acetate, SKY0402, PP110 Gel, and others
The Hemorrhoids epidemiology based on age-based cases analyzed that majority of the patients are older adults
The Hemorrhoids market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hemorrhoids pipeline products will significantly revolutionize the Hemorrhoids market dynamics.

Hemorrhoids Overview
Hemorrhoids, also known as piles, are swollen veins in the lower rectum and anus. They can develop inside the rectum (internal hemorrhoids) or under the skin around the anus (external hemorrhoids).

Get a Free sample for the Hemorrhoids Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/hemorrhoids-market?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=gpr

Hemorrhoids Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Hemorrhoids Epidemiology Segmentation:
The Hemorrhoids market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
Total Prevalence of Hemorrhoids
Prevalent Cases of Hemorrhoids by severity
Gender-specific Prevalence of Hemorrhoids
Diagnosed Cases of Episodic and Chronic Hemorrhoids

Download the report to understand which factors are driving Hemorrhoids epidemiology trends @ Hemorrhoids Epidemiology Forecast

Hemorrhoids Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hemorrhoids market or expected to get launched during the study period. The analysis covers Hemorrhoids market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Hemorrhoids Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Hemorrhoids Therapies and Key Companies
Carraghenates Cream: Xian-Janssen Pharmaceutical Ltd.
Monad: Citius Pharmaceuticals, Inc.
Anusol: Church & Dwight Company, Inc.
Iferanserin: Ventrus Biosciences, Inc
Hydrocortisone acetate: Citius Pharmaceuticals, Inc.
SKY0402: Pacira Pharmaceuticals, Inc
PP110 Gel: Peritech Pharma Ltd.

Hemorrhoids Market Drivers
Rise in awareness about hemorrhoids
Increase in reported cases of hemorrhoids

Hemorrhoids Market Barriers
Lack of specialized personnel and healthcare infrastructure for the treatment of hemorrhoids
The time taking treatment procedure is also a hindrance to the growth of the hemorrhoids treatment market

Scope of the Hemorrhoids Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Hemorrhoids Companies: Xian-Janssen Pharmaceutical Ltd., Citius Pharmaceuticals, Inc., Church & Dwight Company, Inc., Ventrus Biosciences, Inc, Citius Pharmaceuticals, Inc, Pacira Pharmaceuticals, Inc, Peritech Pharma Ltd., and others
Key Hemorrhoids Therapies: Carraghenates Cream, Monad, Anusol, Iferanserin, Hydrocortisone acetate, SKY0402, PP110 Gel, and others
Hemorrhoids Therapeutic Assessment: Hemorrhoids current marketed and Hemorrhoids emerging therapies
Hemorrhoids Market Dynamics: Hemorrhoids market drivers and Hemorrhoids market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Hemorrhoids Unmet Needs, KOL’s views, Analyst’s views, Hemorrhoids Market Access and Reimbursement

To know more about Hemorrhoids companies working in the treatment market, visit @ Hemorrhoids Clinical Trials and Therapeutic Assessment

Table of Contents
1. Hemorrhoids Market Report Introduction
2. Executive Summary for Hemorrhoids
3. SWOT analysis of Hemorrhoids
4. Hemorrhoids Patient Share (%) Overview at a Glance
5. Hemorrhoids Market Overview at a Glance
6. Hemorrhoids Disease Background and Overview
7. Hemorrhoids Epidemiology and Patient Population
8. Country-Specific Patient Population of Hemorrhoids
9. Hemorrhoids Current Treatment and Medical Practices
10. Hemorrhoids Unmet Needs
11. Hemorrhoids Emerging Therapies
12. Hemorrhoids Market Outlook
13. Country-Wise Hemorrhoids Market Analysis (2019–2032)
14. Hemorrhoids Market Access and Reimbursement of Therapies
15. Hemorrhoids Market Drivers
16. Hemorrhoids Market Barriers
17. Hemorrhoids Appendix
18. Hemorrhoids Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Gaurav Bora
DelveInsight Business Research
+1 469-945-7679
email us here